Kein Unternehmensprofil gefunden.
Aktuelle News
News Funktionen
Weitere Funktionen
11 Juli 2015
02:02
Ad-hoc
EN
H. Lundbeck A/S
Ad-hoc
EN
FDA approves Rexulti (brexpiprazole) as adjunctive treatment for adults with major depressive disorder and as a treatment for adults with schizophrenia
23 Juni 2015
17:47
Corporate
EN
H. Lundbeck A/S
Corporate
EN
Young adult patients* with schizophrenia show improved functioning and health-related quality of life with Abilify Maintena® (aripiprazole once-monthly) compared with paliperidone palmitate
14 Juni 2015
09:20
Corporate
EN
H. Lundbeck A/S
Corporate
EN
Major shareholder announcement
2 Juni 2015
02:46
Corporate
EN
H. Lundbeck A/S
Corporate
EN
Total number of voting rights and share capital in H. Lundbeck A/S as of 31 May 2015
21 Mai 2015
11:59
Corporate
EN
H. Lundbeck A/S
Corporate
EN
Lundbeck increases its share capital by 186,676 shares (0.0950% of outstanding shares)
6 Mai 2015
08:06
Corporate
EN
H. Lundbeck A/S
Corporate
EN
Solid performance in the first quarter of the year. Full year guidance maintained
Kursinformation
Für dieses Unternehmen ist kein Kurs-Chart verfügbar.
()